Pergolizzi Joseph V, Magnusson Peter, LeQuang Jo Ann K, Breve Frank, Varrassi Giustino
Clinical Research, NEMA Research, Inc., Naples, USA.
Cardiology, Centre for Research and Development, Region Gävleborg/Uppsala University, Gävle, SWE.
Cureus. 2021 Apr 20;13(4):e14594. doi: 10.7759/cureus.14594.
Long-term cocaine use, as well as acute cocaine use, is associated with adverse cardiovascular consequences, including arrhythmias, angina, myocardial infarction, heart failure, and other conditions. Over the long term, cocaine can result in structural changes to the heart such as increased left-ventricular mass and decreased left-ventricular end-diastolic volume. Patients arriving with cocaine-associated cardiovascular complaints may not be forthcoming about their cocaine or polysubstance abuse or may be unresponsive. The role of beta-blockers, a first-line treatment for many forms of heart disease, is controversial in this population. Cocaine is a powerful sympathomimetic agent, and it was thought that beta-blockade would result in unopposed alpha-adrenergic stimulation and adverse consequences. A number of small, single-center, retrospective and observational studies suggest that beta-blockers may be safe, effective, and beneficial in this population. Further study is needed to clarify the role of beta-blockers in this population.
长期使用可卡因以及急性使用可卡因均与不良心血管后果相关,包括心律失常、心绞痛、心肌梗死、心力衰竭及其他病症。长期来看,可卡因会导致心脏结构改变,如左心室质量增加和左心室舒张末期容积减小。因可卡因相关心血管问题前来就诊的患者可能不会主动提及他们使用可卡因或多种药物滥用的情况,或者可能没有反应。β受体阻滞剂作为多种心脏病的一线治疗药物,在这一人群中的作用存在争议。可卡因是一种强效拟交感神经药,人们曾认为β受体阻滞会导致α肾上腺素能刺激不受抑制并产生不良后果。一些小型、单中心、回顾性和观察性研究表明,β受体阻滞剂在这一人群中可能是安全、有效且有益的。需要进一步研究以阐明β受体阻滞剂在这一人群中的作用。